BIJAN NEJADNIK
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
MARK J. AHN, PH.D., WILLIAM L. ASHTON, JOHN T. BURNS, RICHARD CHIN, RICHARD CHIN, M.D., RYAN DUNLAP, IRVING M. EINHORN, STEPHEN GALLIKER, STEPHEN S. GALLIKER, MARY ANN GRAY, MARY ANN GRAY, PH.D., BRIAN HAMILTON, M.D., PH.D., SANFORD J. HILLSBERG, KATHERINE BACH KALIN, THOMAS J. KNAPP, STEVEN A. KRIEGSMAN, BIJAN NEJADNIK, M.D., RUDOLPH NISI, RUDOLPH NISI, M.D., ROBERT VAN NOSTRAND, DAVID A. SCHEINBERG, MARK W. SCHWARTZ, MARK W. SCHWARTZ, PH.D., ANGELOS M. STERGIOU, ROBERT L. VAN NOSTRAND, JOHN VARIAN, JANE WASMAN, BARBARA A. WOOD
EXECUTIVE OFFICER
MICHAEL CANNON, MICHAEL D. CANNON, VIVIEN CHAN, SANDY CHAU, WAI-YAN "SANDY" CHAU, CHIH-KAI CHENG, CHIH-KAI "C.K." CHENG, BO FENG, QIUSHI FU, HSING KUNG, CHRISTOPHER LEHMAN, CHENG LIU, JACQUELINE S. NORTHCUT, MARVIN T. SAMSON, VICTOR SHUM, WILIAM S. SOLARI III, WILLIAM S. SOLARI III, LEWIS T. WILLIAMS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2018-06-04

